Physician

Alan Lewis, MD

According to 2025 Medicare claims, Alan Lewis, MD (NPI: 1912090143) practices dermatology in the Gulfport-Biloxi, MS market, with the plurality of this provider's patient population coming from Harrison, MS. This provider's primary affiliated billing organization is TULANE DERMATOLOGY AFFILIATES (NPI: 1821285438; TIN: 64-0851076) and primary practice location at 39501-2666.

Lewis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 915 traditional Medicare patients, billed 8,154 HCPCS/CPT codes, and received $658,548 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 698 prescription claims across 288 beneficiaries totaling $72,053 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 7 records totaling $148. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $430,932 to $658,548. Similarly, Part D prescription costs have risen steadily, from $7,074 to $72,053. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$347K$693K2015 Medicare payment: $430,932 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $429,916 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $317,918 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $404,981 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $452,659 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $451,328 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $629,424 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $682,836 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $693,468 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $658,548 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154232,366$430,932
20163752,365$429,916
20173491,910$317,918
20185533,493$404,981
20196964,546$452,659
20207285,594$451,328
20217526,823$629,424
20221,1018,978$682,836
20231,0439,385$693,468
20249158,154$658,548

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$36K$72K2015 Drug cost: $7,074 (USD; Tot_Drug_Cst)2016 Drug cost: $4,481 (USD; Tot_Drug_Cst)2017 Drug cost: $3,410 (USD; Tot_Drug_Cst)2018 Drug cost: $49,220 (USD; Tot_Drug_Cst)2019 Drug cost: $11,373 (USD; Tot_Drug_Cst)2020 Drug cost: $43,628 (USD; Tot_Drug_Cst)2021 Drug cost: $53,008 (USD; Tot_Drug_Cst)2022 Drug cost: $37,523 (USD; Tot_Drug_Cst)2023 Drug cost: $17,903 (USD; Tot_Drug_Cst)2024 Drug cost: $72,053 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015134217$7,074
2016119232$4,481
2017105187$3,410
2018133263$49,220
2019149258$11,373
2020183368$43,628
2021228533$53,008
2022265562$37,523
2023271677$17,903
2024288698$72,053

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks174229$256
11102Biopsy of related skin growth, first growth208235$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7741,510$58
17000Destruction of precancer skin growth, 1 growth6381,039$42
17003Destruction of precancer skin growth, 2-14 growths5443,573$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Clobetasol PropionateClobetasol Propionate581,626$2,854
MetronidazoleMetronidazole321,009$2,372
KetoconazoleKetoconazole1795,380$2,279
Triamcinolone AcetonideTriamcinolone Acetonide1514,774$1,342
Betamethasone DipropionateBetamethasone Dipropionate16622$745

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$148ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alan Lewis, MD?

Tedicare shows public-source Medicare data for Alan Lewis, MD (NPI 1912090143), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan Lewis, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alan Lewis, MD?

Alan Lewis, MD is linked to TULANE DERMATOLOGY AFFILIATES (billing NPI 1821285438) in the available physician profile data.

Does Alan Lewis, MD have Open Payments data?

Alan Lewis, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.